A clinical trial to study the drug Mullangi Chooranam in patients having Peptic Ulcer disease
Phase 2
- Conditions
- Health Condition 1: K279- Peptic ulcer, site unspecified, unspecified as acute or chronic, without hemorrhage or perforation
- Registration Number
- CTRI/2019/09/021198
- Lead Sponsor
- Government siddha medical college
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Duration of illness not more than 10 years Burning epigastric pain Abdominal bloating nausea anorexia vommiting
Exclusion Criteria
Pyloric stenosis carcinoma stomach acute abdominal colic gastric obstruction cholelithiasis pancreatitis appendicitis renal colic
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method